To test this hypothesis, we could investigate the interactions between HLA-DRB1 and new RA risk genes, such as SUPT20H. For this analysis, we would need to perform a study including both individuals carrying and not carrying HLA-DRB1 risk alleles. The gene discussed is HLA-DRB1; the disease is rheumatoid arthritis.